Abstract
Abstract
Human papilloma virus is a deadly virus that causes cervical, penile and vulval cancer. The current effort focuses on HPV's lesser-known proteins, as well as its virulence and prevalence in men and women. The leitmotif of this review is to create drugs against the proteins of the Human papilloma Virus as a suggestive solution against the diseases caused by this virus. The study includes the extraction of the protein sequences of the virus from NCBI, followed with the secondary structure prediction with the aid of the usage of online available protein prediction tools; GOR4, Chou and Fasman and phyre2. Homology modelling using SWISSMODEL was done of each protein (E1, E2, L1 and L2) taken from HPV for receiving the appropriate model for the respective proteins. The PDB files for each of the protein were downloaded and used for docking against respective ligands mentioned in this review. The docking results are elaborately discussed in this study.
Publisher
Research Square Platform LLC
Reference17 articles.
1. Alessandra Handisurya, Christina Schellenbacher, Reinhard Kirnbauer, “Diseases caused by Human Papillomaviruses (HPV)”, Journal of the German Society for Dermatology, JDDG; 2009 • 7:453–466, Submitted: 5. 10. 2008 | Accepted: 7. 11. 2008, DOI: 10.1111/j.1610-0387.2008. 06988.x
2. Satish Kumar, Lingaraja Jena, Maheswata Sahoo, MrunmayiKakde, Sangeeta Daf, and Ashok K. Varma, “In Silico Docking to Explicate Interface between Plant-Originated Inhibitors and E6 Oncogenic Protein of Highly Threatening Human Papillomavirus 18”, Genomics Informv.13(2); 2015 Jun PMC4500800,Published online 2015 Jun 30. doi: 10.5808/GI.2015.13.2.60
3. The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis”;Eun-KyoungYim PhD;Cancer Res Treat,2005
4. Elissa Meites, MD, MPH; Julianne Gee, MPH; Elizabeth Unger, PhD, MD; and Lauri Markowitz, MD, “Human Papilloma Virus”
5. Human papillomavirus-associated cutaneous lesions”;François Aubin René;PubMed,2006